Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218012
Company: NOVUGEN
Company: NOVUGEN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SUNITINIB MALATE | SUNITINIB MALATE | EQ 12.5MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
SUNITINIB MALATE | SUNITINIB MALATE | EQ 25MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
SUNITINIB MALATE | SUNITINIB MALATE | EQ 37.5MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
SUNITINIB MALATE | SUNITINIB MALATE | EQ 50MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/21/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |